In IDH mutant gliomas, neoplastic hypermethylation of transcriptional repressor binding sites leads to the destruction of this binding, resulting in the accumulation of active histone modifications, and finally promote downstream oncogene activation. This evidence concerns the gene IDH2 and glioma.